Zomedica (ZOM) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free ZOM Stock Alerts $0.14 0.00 (0.00%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest Zomedica Short Interest DataCurrent Short Volume60,250,000 sharesPrevious Short Volume60,720,000 sharesChange Vs. Previous Month-0.77%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover11.8Last Record DateApril 30, 2024Outstanding Shares979,950,000 sharesFloat Size964,360,000 sharesShort Percent of Float6.25%Today's Trading Volume17,053,367 sharesAverage Trading Volume5,487,234 sharesToday's Volume Vs. Average311% Short Selling Zomedica ? Sign up to receive the latest short interest report for Zomedica and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatZOM Short Interest Over TimeZOM Days to Cover Over TimeZOM Percentage of Float Shorted Over Time Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. Zomedica Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202460,250,000 shares $0.00 -0.8%6.3%11.8 $0.00 4/15/202460,720,000 shares $0.00 -5.1%6.3%12.8 $0.00 3/31/202463,990,000 shares $0.00 +10.7%6.6%11.5 $0.00 3/15/202457,820,000 shares $0.00 -10.5%6.0%10.3 $0.00 2/29/202464,630,000 shares $9.24 million +13.3%6.7%10.6 $0.14 2/15/202457,050,000 shares $0.00 +2.9%5.9%10.6 $0.00 Get the Latest News and Ratings for ZOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zomedica and its competitors with MarketBeat's FREE daily newsletter. 1/31/202455,430,000 shares $0.00 +0.2%5.8%10.8 $0.00 1/15/202455,340,000 shares $0.00 +3.5%5.7%10.9 $0.00 12/31/202353,460,000 shares $0.00 -17.0%5.7%12.5 $0.00 12/15/202364,430,000 shares $0.00 +1.6%6.7%16.2 $0.00 11/30/202363,430,000 shares $10.66 million +8.3%6.6%19.4 $0.17 11/15/202358,560,000 shares $0.00 -6.9%6.1%17.9 $0.00 10/31/202362,890,000 shares $0.00 +2.1%6.5%18.2 $0.00 10/15/202361,620,000 shares $0.00 -3.4%6.4%18 $0.00 9/30/202363,790,000 shares $0.00 -4.2%6.6%16.4 $0.00 9/15/202366,590,000 shares $0.00 -5.3%6.9%16.7 $0.00 8/31/202370,320,000 shares $0.00 +2.5%7.3%17.1 $0.00 8/15/202368,630,000 shares $0.00 -0.7%7.1%16 $0.00 7/31/202369,120,000 shares $14.52 million +3.1%7.2%16.8 $0.21 7/15/202367,040,000 shares $0.00 +3.2%6.9%16.7 $0.00 6/30/202364,990,000 shares $13.00 million -10.3%6.7%17 $0.20 6/15/202372,470,000 shares $0.00 -8.5%7.5%20.3 $0.00 5/31/202379,230,000 shares $0.00 +13.2%8.2%20.1 $0.00 5/15/202370,020,000 shares $0.00 -17.3%7.3%18.2 $0.00 4/30/202384,650,000 shares $0.00 -0.5%8.8%21.8 $0.00 4/15/202385,090,000 shares $0.00 -4.1%8.8%17.5 $0.00 3/31/202388,690,000 shares $0.00 +2.1%9.2%12.4 $0.00 3/15/202386,850,000 shares $0.00 +4.5%9.0%9.4 $0.00 2/28/202383,090,000 shares $0.00 -7.4%8.6%9 $0.00 2/15/202389,750,000 shares $0.00 -3.1%9.3%9.6 $0.00 1/31/202392,660,000 shares $25.55 million +2.7%9.6%9.3 $0.28 1/15/202390,230,000 shares $0.00 +2.0%9.3%9.2 $0.00 12/30/202288,480,000 shares $0.00 +1.6%9.2%10.9 $0.00 12/15/202287,120,000 shares $0.00 +0.0%9.0%14.2 $0.00 11/30/202287,110,000 shares $0.00 +2.5%9.0%13.3 $0.00 11/15/202285,030,000 shares $0.00 -2.8%8.8%11.4 $0.00 10/31/202287,470,000 shares $0.00 -2.2%9.1%9.3 $0.00 10/15/202289,390,000 shares $0.00 +1.4%9.3%7.6 $0.00 9/30/202288,140,000 shares $0.00 +2.8%9.1%6.9 $0.00 9/15/202285,710,000 shares $0.00 +3.0%8.9%5.5 $0.00Biden FINISHED On June 13th? (Ad)Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered.Click here now to see his shocking evidence. ZOM Short Interest - Frequently Asked Questions What is Zomedica's current short interest? Short interest is the volume of Zomedica shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 60,250,000 shares of ZOM short. 6.25% of Zomedica's shares are currently sold short. Learn More on Zomedica's current short interest. What is a good short interest ratio for Zomedica? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZOM shares currently have a short interest ratio of 12.0. Learn More on Zomedica's short interest ratio. What is a good short interest percentage for Zomedica? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.25% of Zomedica's floating shares are currently sold short. Is Zomedica's short interest increasing or decreasing? Zomedica saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 60,250,000 shares, a drop of 0.8% from the previous total of 60,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Zomedica's float size? Zomedica currently has issued a total of 979,950,000 shares. Some of Zomedica's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Zomedica currently has a public float of 964,360,000 shares. How does Zomedica's short interest compare to its competitors? 6.25% of Zomedica's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Zomedica: Gossamer Bio, Inc. (5.68%), Seres Therapeutics, Inc. (14.17%), ProQR Therapeutics (0.41%), Capricor Therapeutics Inc (13.14%), Skye Bioscience, Inc. (0.29%), Prelude Therapeutics Incorporated (2.43%), Greenwich LifeSciences, Inc. (3.24%), scPharmaceuticals Inc. (17.76%), Newron Pharmaceuticals S.p.A. (0.16%), Incannex Healthcare Inc. (0.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Zomedica stock? Short selling ZOM is an investing strategy that aims to generate trading profit from Zomedica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Zomedica? A short squeeze for Zomedica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZOM, which in turn drives the price of the stock up even further. How often is Zomedica's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZOM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Gossamer Bio Short Interest Seres Therapeutics Short Interest ProQR Therapeutics Short Interest Capricor Therapeutics Short Interest Skye Bioscience Short Interest Prelude Therapeutics Short Interest Greenwich LifeSciences Short Interest scPharmaceuticals Short Interest Newron Pharmaceuticals Short Interest Incannex Healthcare Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:ZOM) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressElon to Transform U.S. Economy? Porter & CompanyThe only AI company you should be looking atBehind the Markets